.jpg)
Equity facility increased by $1.5 billion
The Nasdaq-listed company can raise funds over time by selling newly issued PURR shares to Chardan. Hyperliquid Strategies previously said proceeds from the facility could support general corporate purposes, including potential purchases of HYPE, the native token of the Hyperliquid network. The $2.5 billion commitment represents the facility's maximum aggregate capacity, not a guaranteed raise amount.
Hyperliquid Strategies and Chardan signed the amendment to their equity purchase agreement on September 1. The original agreement dates to October 22, 2025. The amendment raises the total commitment by $1.5 billion. Chardan can purchase newly issued common shares after the company submits qualifying purchase notices under the agreement.
Hyperliquid Strategies controls the timing and amount of individual sales. Its SEC disclosures state that financing decisions will depend on market conditions, PURR's trading price, and management's assessment of how the proceeds should be deployed. The arrangement differs from a traditional loan, as selling shares does not create principal repayments or interest expenses, though it does create potential dilution for existing investors.
Potential HYPE purchases remain optional
Hyperliquid Strategies said in its prospectus that proceeds from equity-facility sales were planned for general corporate purposes, including potential HYPE purchases. That language gives management broad discretion and does not establish a minimum HYPE allocation, purchasing deadline, or fixed token target. The company could also direct proceeds toward operating expenses, transaction costs, or other corporate requirements.
The September 1 filing does not report a new HYPE acquisition. Hyperliquid Strategies reported holding 29.3 million HYPE as of August 19. Since completing its business combination in December 2025, the company had spent $773.4 million to acquire approximately 16.5 million tokens at an average price of $46.77. The company also reported $149.9 million in cash at the end of June and said it carried no debt.
Nasdaq rules limit lower-priced issuances
The amendment introduces an exchange cap that becomes relevant after aggregate share sales through the facility reach $1 billion. After that threshold, Hyperliquid Strategies generally cannot sell more than 42,641,847 shares at prices below $12.02. The limit equals 19.99% of the common shares outstanding immediately before the amendment was executed. The company can exceed the cap if shareholders approve additional issuances under Nasdaq rules.
At $12.02 per share, 42,641,847 shares would represent approximately $512.5 million in gross proceeds. The relationship between the share cap and the expanded commitment could restrict access to the full facility when PURR trades below $12.02. Raising the entire $2.5 billion may require higher sale prices, shareholder approval, or an applicable Nasdaq exception.
PURR closes below amendment threshold
PURR closed at $11.36 on September 1, down approximately 7.3% during regular trading. The stock opened at $11.76 and traded between $11.03 and $12.31, with volume reaching about 24.3 million shares. The closing price placed PURR below the amendment's $12.02 reference level, though the market price does not activate the exchange cap by itself. The restriction concerns completed below-threshold sales after cumulative facility purchases reach $1 billion.
The effect on existing investors will depend on the timing and size of each issuance. Selling shares at lower prices requires the company to issue more stock to raise the same amount of cash, increasing dilution. Hyperliquid Strategies has used equity financing as a central part of its token accumulation strategy, with the transaction that formed the company including $305 million in cash alongside the initial HYPE contribution.
